U.S. investors and large pharmaceutical companies are increasingly doing deals in China as the country’s biopharma sector ...
Vishal Manchanda highlights the potential challenges the pharmaceutical sector may face in FY27 due to reliance on key drugs ...
Big Tech and pharmaceutical companies are accelerating the implementation of artificial intelligence in the healthcare ...
Vaccine policy, Medicare drug negotiations, and a potential DTC advertising ban will all fall under Kennedy’s purview as HHS ...
StockStory.org on MSN1d
Why West Pharmaceutical Services (WST) Stock Is NosedivingShares of healthcare products company West Pharmaceutical Services (NYSE:WST) fell 34.9% in the afternoon session after the ...
Using money from the opioid settlement funds from big pharmaceutical companies, St. Johns County will partner with EPIC ...
Should you invest $1,000 in Hims & Hers Health right now? Before you buy stock in Hims & Hers Health, consider this: The Motley Fool Stock Advisor analyst team just identified wha ...
CN Water is a leading water treatment solution provider with over 150 clients across industries and 700 operational plants ...
Despite the death of its golden goose, AbbVie expects to achieve high single-digit compound annual sales growth to the end of ...
The grants have been the source of new treatments for cancer, heart disease, diabetes, strokes and H.I.V.; wonder drugs like ...
Hims & Hers wants to keep on selling a compounded version of Ozempic. And it's channeling anti-establishment vibes to make its case.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback